Association of beta-adrenoceptor polymorphisms with cardiac autonomic modulation in Japanese males.

Laboratory of Metabolism, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto, Japan.
American heart journal (Impact Factor: 4.56). 10/2007; 154(4):759-66. DOI: 10.1016/j.ahj.2007.03.053
Source: PubMed

ABSTRACT The beta1- and beta2-adrenergic receptors (ARs) coexist in the human heart and control sympathetic responses. Several functional genetic variations in the beta-AR genes (ADRB1 or ADRB2) have been identified and implicated as causes of hypertension and cardiovascular disease. We assessed the relationship between 4 representative genetic polymorphisms of beta-AR (Ser49Gly and Arg389Gly in beta1-AR, Arg16Gly and Gln27Glu in beta2-AR) and autonomic nervous system (ANS) function in healthy young Japanese males.
One hundred forty-nine subjects were genotyped for each beta-AR polymorphism and underwent evaluation of ANS function by power spectral analysis of heart rate variability (HRV) during supine rest and in a standing position. The low-frequency (LF; <0.15 Hz) and high-frequency (HF; >0.15 Hz) components of HRV were quantified by frequency domain analysis and expressed in absolute and normalized units.
The beta2-AR Arg16 homozygous group had a significantly lower diastolic and mean blood pressure than the Gly16 group in both Arg16Gly individual and Gln27Glu polymorphism combined diplotype-based analyses. In a supine rest position, subjects homozygous for the beta2-AR Arg16 allele had significantly lower HRV sympathetic indices (LF [%] and LF/HF ratio) but higher HRV parasympathetic indices (HF [%]) than the Gly16 allele carriers. Meanwhile, the beta2-AR Glu27 allele was significantly associated with higher HRV LF power than were Gln27 homozygous subjects. In the analysis of gene-gene interaction, the effects of the beta2-AR Arg16 homozygotes on HRV were more apparent in the presence of the beta1-AR Gly389 allele. No independent associations were observed between the beta1-AR Ser49Gly or Arg389Gly genotypes and HRV indices.
The Arg16Gly polymorphism of the beta2-AR is related to the modulation of sympathovagal balance, and beta2-AR Glu27 allele carriers potentially have increased autonomic activity. Thus, beta-AR genotype-related differences in basic receptor function cause phenotypic differences in cardiac ANS function.

1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We investigated whether genetic variations of the beta-2 adrenergic receptor (ADRB2) modulate the haemodynamic response following spinal anaesthesia for caesarean delivery. We focused on the effects of haplotypes formed by combinations of the Arg16Gly and Gln27Glu polymorphisms. Clinical data from 143 healthy parturients were collected. Only the ArgGln haplotype appeared to influence the risk of hypotension, most probably through a recessive mode of inheritance (p = 0.027). Therefore, patients were grouped according to ArgGln homozygosity in two groups: presence of one or no copies of the haplotype (n = 120) or two copies of the haplotype (n = 23). Both groups presented similar baseline characteristics. Comparatively, patients homozygous for the ArgGln haplotype presented consistently higher blood pressure levels throughout the evaluation period (p = 0.001 for systolic arterial pressure variation from baseline). In conclusion, our results demonstrate that haplotype variations of the the ADRB2 modulate the haemodynamic response following spinal anaesthesia for caesarean delivery.
    Anaesthesia 08/2012; 67(11):1251-1259. DOI:10.1111/j.1365-2044.2012.07296.x · 3.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This brief tackles the problem of designing suboptimal $H_{2}/H_{\infty}$ controllers for linear networked control systems (NCS) subject to time-varying delays and packet dropouts. The formulation provides state feedback NCS controllers allowing to tradeoff performance and disturbance rejection. The control objective consists in designing an $H_{2}$ suboptimal control minimizing a quadratic performance index, with a disturbance rejection constraint ($H_{\infty}$ constraint). To characterize the network, only the lower and upper bounds for the delay, as well as the maximum number of consecutive dropouts are required. The approach relies on the formulation of the problem in terms of the minimization of a single scalar parameter, that can be cast as a standard linear matrix inequality (LMI) problem, yielding a suboptimal cost-guaranteed solution. As a difference from previous works, the solution provided is independent of initial conditions. Stability and robustness properties of the proposed controller are theoretically demonstrated and tested on an experimental testbed consisting in the stabilization of a robot arm in the proximities of the unstable upright position. The application shows good performance and disturbance rejection capabilities even for stringent network conditions.
    IEEE Transactions on Control Systems Technology 07/2012; 20(4):1057-1065. DOI:10.1109/TCST.2011.2149526 · 2.52 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It has been recently reported in Psychophysiology that carriers of the short allele of an insertion/deletion (ins/del) functional polymorphism in the promoter region (5-HTTLPR) of the serotonin transporter gene may display decreased resting respiratory sinus arrhythmia (RSA). However, this region hosts another functionally connected single-nucleotide polymorphism (rs25531), which should also be genotyped in order to correctly categorize the low- and high-expressing alleles of 5-HTTLPR. The present study investigated resting RSA in an ethnically homogenous sample (N = 143) of participants genotyped for both the ins/del and rs25531 polymorphisms in 5-HTTLPR. In contrast with the biallelic genotypes, based only on the ins/del alleles, the triallelic 5-HTTLPR genotypes (i.e., including rs25531) showed no association with resting RSA. Taking a triallelic approach to 5-HTTLPR is thus necessary in order to avoid false positive results.
    Psychophysiology 08/2012; 49(10):1412-6. DOI:10.1111/j.1469-8986.2012.01445.x · 3.18 Impact Factor